Patents by Inventor Hyuk-Soo Seo

Hyuk-Soo Seo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRPK INHIBITORS
    Publication number: 20240124459
    Abstract: This disclosure relates to compounds of formula (I) as defined in the Specification. This disclosure also relates to methods of synthesizing the compound of formula (I) and using the compounds of formula (I) for treating a disease (e.g., cancer).
    Type: Application
    Filed: June 28, 2021
    Publication date: April 18, 2024
    Inventors: Kenneth C. Anderson, Teru Hideshima, Sirano Dhe-Paganon, Hyuk-Soo Seo, Takashi Mizutani, Tinghu Zhang
  • SARS-COV-2 ANTIGEN NANOPARTICLES AND USES THERE OF
    Publication number: 20240115693
    Abstract: Provided herein are nanoparticles which enhance the immunogenicity of antigens for use in Beta coronavirus (e.g., MERS-CoV, SARS-CoV-1, or SARS-CoV-2) vaccines, as well as immunogenic compositions comprising the antigen nanoparticles and additional adjuvants for further enhancing immunogenicity.
    Type: Application
    Filed: June 23, 2022
    Publication date: April 11, 2024
    Applicants: Children's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Francesco Borriello, Ofer Levy, David J. Dowling, Sirano Dhe-Paganon, Hyuk-Soo Seo
  • MULTI-DISPLAY BASED DEVICE
    Publication number: 20240086135
    Abstract: An electronic device is provided that includes a first display and a second display. The electronic device also includes a processor configured to allocate a first set of resources to the first display and a second set of resources to the second display. The first set of resources is different from the second set of resources. Each of the first set of resources and the second set of resources includes one or more of at least one available hardware resource and at least one available software resource.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 14, 2024
    Inventors: Duk Ki HONG, Hyuk KANG, Jeong Hun KIM, Jae Bong YOO, Kyung Soo LIM, Jun Hak LIM, Min Gyew KIM, Na Jung Seo
  • PRPK INHIBITORS
    Publication number: 20230271966
    Abstract: This disclosure relates to compounds of formula (I) as defined in the Specification. This disclosure also relates to methods of synthesizing the compound of formula (I) and using the compounds of formula (I) for treating a disease (e.g., cancer).
    Type: Application
    Filed: June 28, 2021
    Publication date: August 31, 2023
    Inventors: Kenneth C. Anderson, Teru Hideshima, Sirano Dhe-Paganon, Hyuk-Soo Seo, Takashi Mizutani, Tinghu Zhang
  • NOVEL USP7 INHIBITORS FOR TREATING MULTIPLE MYELOMA
    Publication number: 20230265070
    Abstract: The present disclosure relates to inhibitors of USP7 useful in the treatment of cancers, and other USP7 mediated diseases, having the Formula: wherein R1, R2, R3, R4, R5, R6, and n are described herein.
    Type: Application
    Filed: September 2, 2022
    Publication date: August 24, 2023
    Inventors: Sara Buhrlage, Kenneth C. Anderson, Dharminder Chauhan, Sirano Dhe-Paganon, Xiaoxi Liu, Hyuk-Soo Seo
  • USP7 inhibitors for treating multiple myeloma
    Patent number: 11465983
    Abstract: The present disclosure relates to inhibitors of USP7 useful in the treatment of cancers, and other USP7 mediated diseases, having the Formula: wherein R1, R2, R3, R4, R5, R6, and n are described herein.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: October 11, 2022
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Sara Buhrlage, Kenneth C. Anderson, Dharminder Chauhan, Sirano Dhe-Paganon, Xiaoxi Liu, Hyuk-Soo Seo
  • PEPTIDOMIMETIC INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1)
    Publication number: 20210238225
    Abstract: Disclosed are compounds which inhibit Pin1 activity, methods of making the compounds, pharmaceutical compositions containing the compounds, and methods of using the compounds to treat diseases or disorders characterized or mediated by dysregulated Pin1 activity.
    Type: Application
    Filed: June 13, 2019
    Publication date: August 5, 2021
    Applicants: DANA-FARBER CANCER INSTITUTE, INC., BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
    Inventors: Nathanael GRAY, Benika PINCH, Sirano DHE-PAGANON, Hyuk-Soo SEO, Chris BROWNE, Jarrod MARTO, Zainab DOCTOR, Kun Ping LU, Xiao ZHOU, Shingo KOZONO, Xiaolan LIAN
  • NOVEL USP7 INHIBITORS FOR TREATING MULTIPLE MYELOMA
    Publication number: 20200347031
    Abstract: The present disclosure relates to inhibitors of USP7 useful in the treatment of cancers, and other USP7 mediated diseases, having the Formula: wherein R1, R2, R3, R4, R5, R6, and n are described herein.
    Type: Application
    Filed: September 26, 2018
    Publication date: November 5, 2020
    Inventors: Sara Buhrlage, Kenneth C. Anderson, Dharminder Chauhan, Sirano Dhe-Paganon, Xiaoxi Liu, Hyuk-Soo Seo